日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Evaluation of the Efficacy and Safety of a Dual Delayed-Release Formulation of 10-mg Esomeprazole in Patients with Gastric Erosions: A Multicenter, Randomized, Double-Blind, Active-Control, Phase III Study

评估10毫克埃索美拉唑双重缓释制剂治疗胃糜烂患者的疗效和安全性：一项多中心、随机、双盲、阳性对照的III期研究

期刊:Gut and Liver
影响因子:3.2
doi:10.5009/gnl240390
Lim, Hyun; Lee, Ju Yup; Kwon, Yong Hwan; Moon, Hee Seok; Park, Jong Kyu; Kim, Ki Bae; Kim, Sang Wook; Youn, Young Hoon; Kim, Sang Gyun; Kim, Gwang Ha; Kim, Ji Won; Jang, Jae-Young; Kwon, Kye Sook; Kwon, Joong Goo; Kim, Hyun-Soo; Hong, Su Jin; Lee, Kwang Jae; Choi, Suck Chei; Moon, Jeong Seop; Kim, Nayoung; Park, Jong-Jae; Lim, Yirang; Hong, Sung Hee; Jung, Hwoon-Yong
发表日期：2025
文献求助 收藏

Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants

氨氯地平、氯沙坦、依泽替米贝和瑞舒伐他汀固定剂量复方制剂的药代动力学及其与健康受试者同时服用四种单一成分的比较

期刊:Drugs in Research & Development
影响因子:2.1
doi:10.1007/s40268-024-00460-y
Park, Jin-Woo; Chung, Hyewon; Kim, Jong-Min; Kim, Na Young; Hong, Sung Hee; Kim, Kyoung-Ah; Park, Ji-Young
发表日期：2024
文献求助 收藏

[Production and Management of Reference Materials for Infectious Disease Laboratory Testing]

【传染病实验室检测参考物质的生产与管理】

期刊:
影响因子:
doi:10.56786/PHWR.2024.17.49.4
Oh, Eun-Bi; Hong, Sung-Hee; Lee, Eun-Ju; Rhee, Jee Eun; Kim, Eun-Jin
微生物学
传染病
传染病
发表日期：2024
文献求助 收藏

Pharmacokinetic Interactions Between Bazedoxifene and Cholecalciferol: An Open-Label, Randomized, Crossover Study in Healthy Male Volunteers

巴泽多昔芬与胆钙化醇的药代动力学相互作用：一项在健康男性志愿者中进行的开放标签、随机、交叉研究

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S399264
Lee, Moon Hee; Yoon, Seok-Kyu; Kim, Hyungsub; Cho, Yong-Soon; Han, Sungpil; Lee, Shi Hyang; Bae, Kyun-Seop; Jung, Jina; Hong, Sung Hee; Lim, Hyeong-Seok
发表日期：2023
文献求助 收藏

Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects

在健康受试者中，新型双缓释制剂埃索美拉唑 20 毫克或 40 毫克的药代动力学和药效学研究

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S392533
Kim, Hyun Chul; Yang, Eunsol; Ban, Mu Seong; Kim, Yu Kyong; Hong, Sung Hee; Jung, Jina; Jang, In-Jin; Lee, SeungHwan
发表日期：2023
文献求助 收藏

Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study

一项多中心、随机、双盲、非劣效性研究，比较了HIP1601（双重缓释埃索美拉唑）40 mg与HGP1705（缓释埃索美拉唑）40 mg治疗糜烂性食管炎的疗效和安全性。

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-023-03087-6
Lim, Hyun; Park, Jong Kyu; Chung, Hyunsoo; Lee, Si Hyung; Park, Jae Myung; Park, Jung Ho; Kim, Gwang Ha; Shin, Sung Kwan; Hong, Su Jin; Lee, Kwang Jae; Park, Moo In; Jung, Hye-Kyung; Kim, Hyun-Soo; Sung, Jae Kyu; Jeon, Seong Woo; Choi, Suck Chei; Moon, Jeong Seop; Kim, Nayoung; Park, Jong-Jae; Hong, Sung Hee; Kim, Na Young; Jung, Hwoon-Yong
发表日期：2023
文献求助 收藏

PB01 suppresses radio-resistance by regulating ATR signaling in human non-small-cell lung cancer cells

PB01 通过调节人类非小细胞肺癌细胞中的 ATR 信号传导来抑制放射抗性

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-021-91716-z
Tae Woo Kim, Da-Won Hong, Sung Hee Hong
信号转导
肿瘤
肺癌
肿瘤细胞
WB
Human
BAX
发表日期：2021
文献求助 收藏

CB13, a novel PPARγ ligand, overcomes radio-resistance via ROS generation and ER stress in human non-small cell lung cancer

CB13 是一种新型 PPARγ 配体，可通过 ROS 生成和 ER 应激克服人类非小细胞肺癌的放射抗性

期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/s41419-020-03065-w
Tae Woo Kim, Da-Won Hong, Sung Hee Hong
肿瘤
肺癌
其它细胞
Human
发表日期：2020
文献求助 收藏

First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients.

抗肝细胞生长因子抗体（YYB101）治疗难治性实体瘤患者的首次人体 I 期试验

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/1758835920926796
Kim Seung Tae, Hong Jung Yong, Park Se Hoon, Park Joon Oh, Park Young Whan, Park Neunggyu, Lee Hukeun, Hong Sung Hee, Lee Song-Jae, Song Seong-Won, Kim Kyung, Park Young Suk, Lim Ho Yeong, Kang Won Ki, Nam Do-Hyun, Lee Jeong-Won, Park Keunchil, Kim Kyoung-Mee, Lee Jeeyun
细胞生物学
Human
发表日期：2020
文献求助 收藏

Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer

增强对游离 DNA (cfDNA) 的检测，使其成为诊断和预后胃癌的可靠生物标志物

期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0242145
Jiyoon Bu, Tae Hee Lee, Woo-Jin Jeong, Michael J Poellmann, Kara Mudd, Hyuk Soo Eun, Elizabeth W Liu, Seungpyo Hong, Sung Hee Hyun
肿瘤
胃癌
发表日期：2020
文献求助 收藏